Can We Reliably Needle Hip Muscles Blindly?
Can We Reliably Needle Hip Region Muscles Without Imaging? A Muscle-Specific Accuracy Study Using Ultrasound
1 other identifier
interventional
40
0 countries
N/A
Brief Summary
The aim of this study is to evaluate the accuracy of invasive interventions (dry needling or injection) performed on specific muscles of the hip region in reaching the anatomical target. The accuracy of the interventions performed with a blinded method will be compared with an observational assessment supported by ultrasonography. The interventions will be performed by a physician with clinical experience, and the anatomical location of the needle tip will be evaluated by a second physician with ultrasonography after each procedure. The targeted muscles include the iliacus, pectineus, sartorius, tensor fascia latae, and rectus femoris. Each participant will be subjected to interventions for five different muscles, and a total of at least 40 injection interventions will be analyzed. Ultrasonography will be used only for observation and verification purposes; no pharmacological substances will be applied during the procedure. All procedures will be performed under sterile conditions, and participants will be monitored for 24 hours for possible pain, bruising, or complications. Participants will be informed about the content and purpose of the study, and written informed consent forms will be obtained. The study does not have a therapeutic purpose and is only intended to investigate targeting accuracy. The data to be obtained is expected to contribute to the determination of anatomical accuracy rates in clinical practices and the improvement of interventional training processes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2025
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 23, 2025
CompletedFirst Posted
Study publicly available on registry
July 22, 2025
CompletedStudy Start
First participant enrolled
September 28, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2025
CompletedSeptember 19, 2025
September 1, 2025
2 days
June 23, 2025
September 18, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Accuracy of Blinded Dry Needling Injections
Proportion of injection attempts in which the needle accurately reaches the intended target muscle using the blinded (anatomical landmark-based) technique, as confirmed by ultrasonography.
Immediately after each injection attempt
Secondary Outcomes (1)
Accuracy Rate per Target Muscle
Immediately after each injection attempt
Other Outcomes (1)
Inter-Operator Variability in Injection Accuracy
2 week
Study Arms (1)
Blind Dry Needling Lumbar Paraspinal Muscles
EXPERIMENTALDry needling is performed using anatomical landmarks without ultrasound guidance. Needle placement is then confirmed via ultrasound imaging.
Interventions
Dry needling is performed using anatomical landmarks without ultrasound guidance. Needle placement is then confirmed via ultrasound imaging.
Eligibility Criteria
You may qualify if:
- Adults aged 18 to 65 years
- Individuals with nonspecific hip, groin, or anterior thigh pain who are scheduled for physical therapy
- Clinical suspicion of myofascial pain syndrome, particularly involving muscles around the hip
- Patients with clinical indication for dry needling or similar invasive treatments (e.g., targeting muscles such as iliacus, pectineus, sartorius)
- Ability to cooperate with the procedure
- Ability to provide written informed consent
You may not qualify if:
- Use of anticoagulant medications (due to increased risk of bleeding)
- Severe hip osteoarthritis, presence of hip prosthesis, history of previous hip surgery, or significant anatomical deformity
- Active infection or skin lesion at the planned injection site
- Inability to cooperate or communicate effectively
- Pregnancy
- Presence of serious systemic illnesses (e.g., malignancy, neurological disorders)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- dr.
Study Record Dates
First Submitted
June 23, 2025
First Posted
July 22, 2025
Study Start
September 28, 2025
Primary Completion
September 30, 2025
Study Completion
September 30, 2025
Last Updated
September 19, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share
There is no plan to share individual participant data (IPD) from this study.